Therapeutic Effects of Combination Therapy and Photobiomodulation Therapy on Retinal Regeneration
Journal of Lasers in Medical Sciences,
Vol. 13 (2022),
10 January 2022
,
Page e36
Abstract
Introduction: Macular edema (ME) is produced by central extravascular inflammation of the macula subsequent to a major loss of visual action. Macular edema can happen at any phase of diabetic retinopathy, whether non-proliferative or proliferative retinopathy.
Method and material: Articles were collected from four electronic databases PubMed, Google Scholar Web of Science from 2000 to 2022 and electronically to study the effects of macular laser grid photocoagulation on Diabetic macular edema or Cystoid macular edema through the keywords " macular laser photocoagulation ", " macular edema ", " Cystoid macular edema ", " Intravitreal pharmacotherapies ", " Antivascular endothelial growth factor “, were searched about 219 articles found in google scholar and 165 articles in PubMed, that 58 articles were included in the study.
Result: In this study, the effects of various laser photocoagulation such as Focal and/or grid macular laser, subthreshold micropulse laser (SMPL), and Intravitreal pharmacotherapies (Corticosteroids such as triamcinolone acetonide, fluocinolone, Bevacizumab, and dexamethasone) on macular edema were investigated. A few studies had shown that the effects of corticosteroids are more effective than lasers, and a number of studies have found the effects of lasers and the combined effects of lasers with corticosteroids to be more effective. Also, some studies have also shown that the frequency and duration of follow-up and concentrations of intravitreal pharmacotherapies are effective in increasing visual outcomes.
Conclusion: The results of studies showed that although corticosteroids have side effects, the combined effects of corticosteroids with subthreshold micropulse laser are effective in increasing visual acuity (VA) and central macular thickness (CMT).
- Macular laser grid photocoagulation, Cystoid macular edema, Diabetic macular edema, Intravitreal pharmacotherapies.
How to Cite
References
2. Hesse, L. and P. Kroll, What is the ophthalmologic recommendation for managing diabetes with reference to diabetic retinopathy. Der Internist, 1993. 34(5): p. 477
3. Meyer, C.H., Current treatment approaches in diabetic macular edema. Ophthalmologica, 2007. 221(2): p. 118-131
4. Gass, J., D.R. Anderson, and E.B. Davis, A clinical, fluorescein angiographic, and electron microscopic correlation of cystoid macular edema. American journal of ophthalmology, 1985. 100(1): p. 82-86
5. Tranos, P.G., et al., Macular edema. Survey of ophthalmology, 2004. 49(5): p. 470-490
6. Network, D.R.C.R., A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology, 2008. 115(9): p. 1447-1459. e10
7. Luttrull, J., D. Musch, and M. Mainster, Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. British Journal of Ophthalmology, 2005. 89(1): p. 74-80
8. Lavinsky, D., et al., Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Investigative Ophthalmology & Visual Science, 2011. 52(7): p. 4314-4323
9. Chen, G., et al., Subthreshold micropulse diode laser versus conventional laser photocoagulation for diabetic macular edema. Retina, 2016. 36(11): p. 2059-2065
10. Figueira, J., et al., Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. British Journal of Ophthalmology, 2009. 93(10): p. 1341-1344
11. Ahn, J.M., S.Y. Lee, and J.S. Yoon, Health-related quality of life and emotional status of anophthalmic patients in Korea. American journal of ophthalmology, 2010. 149(6): p. 1005-1011. e1
12. Park, Y.G., E.Y. Kim, and Y.J. Roh, Laser-based strategies to treat diabetic macular edema: history and new promising therapies. Journal of Ophthalmology, 2014. 2014
13. Nakai, M., et al., Visualization of microaneurysms in macular telangiectasia type 1 on optical coherence tomography angiography before and after photocoagulation. Graefe's Archive for Clinical and Experimental Ophthalmology, 2021. 259(6): p. 1513-1520
14. Francone, A., et al., Effect of laser photocoagulation on macular edema associated with macular holes. Retinal Cases & Brief Reports, 2021. 15(6): p. 730
15. Bressler, S.B., et al., Factors associated with visual acuity and central subfield thickness changes when treating diabetic macular edema with anti–vascular endothelial growth factor therapy: an exploratory analysis of the protocol T randomized clinical trial. JAMA ophthalmology, 2019. 137(4): p. 382-389
16. Kikushima, W., et al., Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema. Pharmaceuticals, 2021. 14(11): p. 1100
17. Takashina, H., et al., Factors Influencing Threshold Energy in Subthreshold Photocoagulation for Diabetic Macular Edema. Clinical Ophthalmology (Auckland, NZ), 2021. 15: p. 1827
18. Avitabile, T., A. Longo, and A. Reibaldi, Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. American journal of ophthalmology, 2005. 140(4): p. 695. e1-695. e10
19. Kang, S.W., et al., Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema. Archives of Ophthalmology, 2006. 124(5): p. 653-658
20. Group, B.V.O.S., Argon laser photocoagulation for macular edema in branch vein occlusion. American journal of ophthalmology, 1984. 98(3): p. 271-282
21. Inagaki, K., et al., Subthreshold micropulse photocoagulation for persistent macular edema secondary to branch retinal vein occlusion including best-corrected visual acuity greater than 20/40. Journal of Ophthalmology, 2014. 2014
22. Hamada, M., et al., Subthreshold photocoagulation using endpoint management in the PASCAL® system for diffuse diabetic macular edema. Journal of Ophthalmology, 2018. 2018
23. Kumar, B., et al., The distribution of angioarchitectural changes within the vicinity of the arteriovenous crossing in branch retinal vein occlusion. Ophthalmology, 1998. 105(3): p. 424-427
24. Maár, N., et al., Effect of Laser Photocoagulation on the Retinal Vessel Diameter inBranch and Macular Vein Occlusion. Archives of ophthalmology, 2004. 122(7): p. 987-991
25. Arslan, U., Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser. Lasers in Medical Science, 2021. 36(2): p. 317-323
26. Network, D.R.C.R., Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Archives of Ophthalmology, 2009. 127(2): p. 132-140
27. Ramchandran, R.S., et al., Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. American journal of ophthalmology, 2008. 146(2): p. 285-291. e1
28. Edelman, J.L., D. Lutz, and M.R. Castro, Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood–retinal and blood–aqueous barrier breakdown. Experimental eye research, 2005. 80(2): p. 249-258
29. Antonetti, D.A., et al., Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. Journal of neurochemistry, 2002. 80(4): p. 667-677
30. Elman, M.J., et al., Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology, 2011. 118(4): p. 609-614
31. Bressler, S.B., et al., Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment. JAMA ophthalmology, 2015. 133(5): p. 589-597
32. Aiello, L.P., et al., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine, 1994. 331(22): p. 1480-1487
33. Bae, Y.H., et al., Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion. Journal of Ophthalmology, 2021. 2021
34. Network, D.R.C.R., Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Archives of ophthalmology, 2009. 127(3): p. 245-251
35. Chew, E.Y., Laser Photocoagulation and Intravitreal Injection of Triamcinolone for Retinal Vein OcclusionsTREATMENT FOR RETINAL VEIN OCCLUSIONS. JAMA, 2009. 302(15): p. 1693-1695
36. Jonas, J.B., et al., Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study. Journal of Ocular Pharmacology & Therapeutics, 2006. 22(3): p. 200-207
37. Bashshur, Z.F., et al., Intravitreal Triamcinolone for the Management of Macular Edema Dueto Nonischemic Central Retinal Vein Occlusion. Archives of ophthalmology, 2004. 122(8): p. 1137-1140
38. Ip, M.S., et al., Intravitreal Triamcinolone for the Treatment of Macular Edema AssociatedWith Central Retinal Vein Occlusion. Archives of ophthalmology, 2004. 122(8): p. 1131-1136
39. Jonas, J.B., et al., Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Archives of Ophthalmology, 2003. 121(1): p. 57-61
40. Karasu, B., Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors. International Ophthalmology, 2020. 40(3): p. 677-687
41. Tariq, F., et al., Efficacy of Intravitreal Injection of Filtered Modified Low-Dose Triamcinolone Acetonide and Ranibizumab on Pseudophakic Cystoid Macular Edema. Frontiers in Medicine, 2022. 9
42. Qamar, R.M.R., M.I. Saleem, and M.F. Saleem, Comparison of the efficacy between an intravitreal and a posterior subtenon injection of triamcinolone acetonide for the treatment of diffuse diabetic macular edema. The Eurasian Journal of Medicine, 2013. 45(3): p. 185
43. Pikkel, J., et al., Bevacizumab for CRVO associated CME: effect of timing and frequency of injections on final visual outcome. Journal of ophthalmology, 2013. 2013
44. Rajendram, R., et al., A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Archives of ophthalmology, 2012. 130(8): p. 972-979
45. Wang, J.-K., et al., Comparison of the efficacy of intravitreal aflibercept and bevacizumab for macular edema secondary to branch retinal vein occlusion. Journal of Ophthalmology, 2016. 2016
46. Scott, I.U., et al., Effect of bevacizumab vs aflibercept on visual acuity among patients with macular edema due to central retinal vein occlusion: the SCORE2 randomized clinical trial. Jama, 2017. 317(20): p. 2072-2087
47. Haller, J.A., et al., Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Archives of Ophthalmology, 2010. 128(3): p. 289-296
48. Shi, R., et al., Aggravation of retinal hard exudates after intravitreal anti-vascular endothelial growth factor therapy for cystoid macular edema and the risk factors: a retrospective study. BMC ophthalmology, 2022. 22(1): p. 1-12
49. Mori, Y., et al., Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema. PLoS One, 2017. 12(4): p. e0175809
50. Hirashima, T., et al., Intravitreal bevacizumab alone or combined with macular laser photocoagulation for recurrent or persistent macular edema secondary to branch retinal vein occlusion. Journal of Ophthalmology, 2014. 2014
51. Ozkaya, A., et al., Comparison between intravitreal triamcinolone with grid laser photocoagulation versus bevacizumab with grid laser photocoagulation combinations for branch retinal vein occlusion. International Scholarly Research Notices, 2013. 2013
52. Wells, J.A., et al., Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. The New England journal of medicine, 2015. 372(13): p. 1193-1203
53. Maturi, R.K., et al., Effect of adding dexamethasone to continued ranibizumab treatment in patients with persistent diabetic macular edema: a DRCR network phase 2 randomized clinical trial. JAMA ophthalmology, 2018. 136(1): p. 29-38
54. Wykoff, C.C., et al., Intravitreal aflibercept injection in eyes with substantial vision loss after laser photocoagulation for diabetic macular edema: subanalysis of the VISTA and VIVID randomized clinical trials. JAMA ophthalmology, 2017. 135(2): p. 107-114
55. Weingessel, B., et al., Treatment of diabetic macular edema with intravitreal antivascular endothelial growth factor and prompt versus deferred focal laser during long-term follow-up and identification of prognostic retinal markers. Journal of Ophthalmology, 2018. 2018
56. Terashima, H., et al., Combination therapy of intravitreal ranibizumab and subthreshold micropulse photocoagulation for macular edema secondary to branch retinal vein occlusion: 6-month result. Retina (Philadelphia, Pa.), 2019. 39(7): p. 1377
57. Hirano, T., et al., Outcomes of a 2-year treat-and-extend regimen with aflibercept for diabetic macular edema. Scientific reports, 2021. 11(1): p. 1-8
58. Adelman, R., et al., Strategy for the management of diabetic macular edema: the European vitreo-retinal society macular edema study. BioMed research international, 2015. 2015
- Abstract Viewed: 593 times
- PDF Downloaded: 396 times